Valuation RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq Stockholm
10:30:00 06/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 176.70 SEK | +1.03% |
|
-12.87% | -22.50% |
| 06/11 | Handelsbanken Fonder increases stake in RaySearch above 5 percent | FW |
| 06/11 | RaySearch's new reirradiation tool used on patient for the first time | FW |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 5,940 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -24% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 6,106 | 5,973 | 5,776 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -21.75% | -2.18% | -3.3% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 22.9x | 17.9x | 15.9x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 7.01x | 5.97x | 4.92x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1.4x | 0.6x | 1.3x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 4.22x | 3.68x | 3.25x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 4.34x | 3.7x | 3.16x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 9.81x | 8.15x | 6.79x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 18.1x | 14.1x | 10.9x |
| EV / FCF | 234x | - | - | - | 21.7x | 25.3x | 17.7x | 16.6x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 3.95% | 5.64% | 6.02% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 4.5 | 5.55 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 2.26% | 2.55% | 3.14% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 7.705 | 9.85 | 11.1 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 51.9% | 45.7% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,407 | 1,614 | 1,827 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 622.5 | 732.5 | 850.5 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 336.5 | 423.5 | 530 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 258 | 328 | 412 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | 166 | 33 | -164 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 176.70 | 176.70 | 176.70 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 33,618 | - | - |
| Announcement Date | 23/02/22 | 28/02/23 | 23/02/24 | 21/02/25 | 12/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.41x | 4.3x | 9.61x | 2.29% | 60Cr | |
| 34.66x | 5.93x | 22.65x | 0.27% | 25TCr | |
| 53.97x | 13.11x | 28.13x | -.--% | 16TCr | |
| 35.98x | 6.85x | 21.44x | 0.64% | 16TCr | |
| 18.26x | 3.59x | 11.7x | -.--% | 6.47TCr | |
| 39.97x | 8.04x | 25.42x | -.--% | 5.8TCr | |
| 22.04x | 2.61x | 13.16x | 2.29% | 5.62TCr | |
| 47.48x | 11.69x | 25.77x | -.--% | 5.02TCr | |
| 33.47x | 6.63x | 22.53x | 0.6% | 4.84TCr | |
| 110.61x | 7.51x | 22.85x | -.--% | 4.45TCr | |
| Average | 41.88x | 7.03x | 20.33x | 0.61% | 8.95TCr | |
| Weighted average by Cap. | 41.19x | 7.59x | 22.39x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
